YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vytorin
Simvastatin and Amiodarone Linked to Possibly Fatal Muscle Disease
Aug 8, 2008 | Parker Waichman Alonso LLP
The combination of simvastatin and amiodarone, an anti-arrhythmia medication, has been linked to a rare muscle condition that can cause kidney damage...
Vytorin - Cancer Link Draws Congressional Scrutiny
Aug 1, 2008 | Parker Waichman Alonso LLP
Lawmakers on a congressional committee want to see the results of a new study that indicated patients taking Vytorin might be at a higher risk of...
Vytorin Makers Defend Drug Following Cancer Findings
Jul 24, 2008 | Parker Waichman Alonso LLP
Vytorin makers Merck and Schering-Plough are preparing to send a letter to thousands of physicians in an attempt to address cancer concerns raised by...
Another Vytorin Failure
Jul 22, 2008 | Parker Waichman Alonso LLP
Yesterday's news that Vytorin failed to meet the primary endpoint in another important study has not done much to restore faith in the controversial...
Vytorin Falls Short in Another Study, Possible Cancer Link Found
Jul 21, 2008 | Parker Waichman Alonso LLP
Vytorin, the controversial cholesterol drug sold by Merck and Schering-Plough, failed to meet the main goal in another important study. What's...
Drug Makers Decry FDA Safety Push
Jul 1, 2008 | Parker Waichman Alonso LLP
Drug makers are complaining that the Food & Drug Administration (FDA) is too focused on, of all things, safety. The pharmaceutical industry...
Senator McCain Quit Vytorin After ENHANCE
May 28, 2008 | Parker Waichman Alonso LLP
Many former Vytorin patients switched off the expensive drug after a study -called ENHANCE - released earlier this year showed it was no more...
Vytorin Study Probed by US Justice Department
May 9, 2008 | Parker Waichman Alonso LLP
The US Justice Department wants to know more about a crucial Vytorin study, the results of which were concealed for more than a year. ...
Lawmakers Lean on FDA to Police Drug Advertising
May 8, 2008 | Parker Waichman Alonso LLP
Last month, Congress asked the Food and Drug Administration (FDA) to speed its efforts in forcing drug companies to include safety-reporting...
Vytorin, Procrit, Lipitor TV Ads Subject of Congress Probe
May 6, 2008 | Parker Waichman Alonso LLP
A U.S. congressional panel is now examining television ads for cholesterol drugs Lipitor and Vytorin and for the anemia drug Procrit at a Thursday...
Vytorin
